Anna brings over two decades of experience shaping U.S. health policy, with extensive knowledge in FDA policy and legislative advocacy. Anna has shaped U.S. health policy at the highest levels of government, she has held senior leadership roles, including deputy commissioner for policy, legislation, and international affairs at the Food and Drug Administration (FDA) and associate director at The White House Domestic Policy Council. Anna brings extensive Capitol Hill experience, she served as health policy director and senior advisor to Sen. Richard Burr (R-NC) and worked at the Senate Health, Education, Labor and Pensions (HELP) Committee. Anna is recognized for her strategic foresight and ability to build bipartisan coalitions, advancing reforms that cross political divides. Her hands-on approach and seasoned know-how position her clients to achieve tangible results in a complex policy environment. She is a trusted advisor known for her leadership in crafting policy and navigating the policymaking process to achieve results on a range of health care, life science, and public health issues. Anna’s leadership and influence in health policy have been recognized nationally. She was named one of Washingtonian’s 500 Most Influential People Shaping Policy (2025), listed among The Hill’s Top Lobbyists, Hired Guns (2024-2025), and honored by the National Institute for Lobbying & Ethics as a Top Lobbyist (2022-2023). Anna holds a B.A. from the University of Pennsylvania, magna cum laude, 2003.